Slide 17
Slide 17 text
LINCS L1000 Chem Pert,
C646,
Chelerythrine chloride, Canertinib
BX-795, Sorafenib,
QL-X-138,
Radicicol,A-443654,CGP-60474,
Alvocidib,
QL-XII-47,
Mitoxantrone,
Geldanamycin,
These are possible SARS-CoV-2 drug repositioning target.